The global market for Human Prothrombin Complex was estimated to be worth US$ 1577 million in 2023 and is forecast to a readjusted size of US$ 3473.8 million by 2030 with a CAGR of 11.8% during the forecast period 2024-2030

Human Prothrombin Complex - Market

Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.

Global Human Prothrombin Complex key players include Octapharma, Shire, CSL, etc. Global top three manufacturers hold a share over 75%.

North America is the largest market, with a share about 45%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.

In terms of product, 500 IU/Vial is the largest segment, with a share over 50%. And in terms of application, the largest application is Hemophilia B, followed by Vitamin K Deficiency, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Prothrombin Complex, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Human Prothrombin Complex by region & country, by Type, and by Application.

The Human Prothrombin Complex market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Prothrombin Complex.

Market Segmentation

Scope of Human Prothrombin Complex - Market Report

Report Metric	Details
Report Name	Human Prothrombin Complex - Market
Forecasted market size in 2030	US$ 3473.8 million
CAGR	11.8%
Forecasted years	2024 - 2030
Segment by Type:	500 IU/Vial 600 IU/Vial 1000 IU/Vial Others
Segment by Application	Hemophilia B Vitamin K Deficiency Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Takeda, CSL, Grifols, Octapharma, Hualan Biological, Meheco Xinxing Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Human Prothrombin Complex manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Human Prothrombin Complex in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Human Prothrombin Complex in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Human Prothrombin Complex - Market size in 2030?

Ans: The Human Prothrombin Complex - Market size in 2030 will be US$ 3473.8 million.

What is the market share of major companies in Human Prothrombin Complex - Market?

Ans: Global top three manufacturers hold a share over 75%.

What is the Human Prothrombin Complex - Market share by type?

Ans: In terms of product, 500 IU/Vial is the largest segment, with a share over 50%.

Who are the main players in the Human Prothrombin Complex - Market report?

Ans: The main players in the Human Prothrombin Complex - Market are Takeda, CSL, Grifols, Octapharma, Hualan Biological, Meheco Xinxing Pharma

What are the Application segmentation covered in the Human Prothrombin Complex - Market report?

Ans: The Applications covered in the Human Prothrombin Complex - Market report are Hemophilia B, Vitamin K Deficiency, Others

What are the Type segmentation covered in the Human Prothrombin Complex - Market report?

Ans: The Types covered in the Human Prothrombin Complex - Market report are 500 IU/Vial, 600 IU/Vial, 1000 IU/Vial, Others

1 Market Overview

1.1 Human Prothrombin Complex Product Introduction

1.2 Global Human Prothrombin Complex Market Size Forecast

1.2.1 Global Human Prothrombin Complex Sales Value (2019-2030)

1.2.2 Global Human Prothrombin Complex Sales Volume (2019-2030)

1.2.3 Global Human Prothrombin Complex Sales Price (2019-2030)

1.3 Human Prothrombin Complex Market Trends & Drivers

1.3.1 Human Prothrombin Complex Industry Trends

1.3.2 Human Prothrombin Complex Market Drivers & Opportunity

1.3.3 Human Prothrombin Complex Market Challenges

1.3.4 Human Prothrombin Complex Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Human Prothrombin Complex Players Revenue Ranking (2023)

2.2 Global Human Prothrombin Complex Revenue by Company (2019-2024)

2.3 Global Human Prothrombin Complex Players Sales Volume Ranking (2023)

2.4 Global Human Prothrombin Complex Sales Volume by Company Players (2019-2024)

2.5 Global Human Prothrombin Complex Average Price by Company (2019-2024)

2.6 Key Manufacturers Human Prothrombin Complex Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Human Prothrombin Complex Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Human Prothrombin Complex

2.9 Human Prothrombin Complex Market Competitive Analysis

2.9.1 Human Prothrombin Complex Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Human Prothrombin Complex Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Prothrombin Complex as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 500 IU/Vial

3.1.2 600 IU/Vial

3.1.3 1000 IU/Vial

3.1.4 Others

3.2 Global Human Prothrombin Complex Sales Value by Type

3.2.1 Global Human Prothrombin Complex Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Human Prothrombin Complex Sales Value, by Type (2019-2030)

3.2.3 Global Human Prothrombin Complex Sales Value, by Type (%) (2019-2030)

3.3 Global Human Prothrombin Complex Sales Volume by Type

3.3.1 Global Human Prothrombin Complex Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Human Prothrombin Complex Sales Volume, by Type (2019-2030)

3.3.3 Global Human Prothrombin Complex Sales Volume, by Type (%) (2019-2030)

3.4 Global Human Prothrombin Complex Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hemophilia B

4.1.2 Vitamin K Deficiency

4.1.3 Others

4.2 Global Human Prothrombin Complex Sales Value by Application

4.2.1 Global Human Prothrombin Complex Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Human Prothrombin Complex Sales Value, by Application (2019-2030)

4.2.3 Global Human Prothrombin Complex Sales Value, by Application (%) (2019-2030)

4.3 Global Human Prothrombin Complex Sales Volume by Application

4.3.1 Global Human Prothrombin Complex Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Human Prothrombin Complex Sales Volume, by Application (2019-2030)

4.3.3 Global Human Prothrombin Complex Sales Volume, by Application (%) (2019-2030)

4.4 Global Human Prothrombin Complex Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Human Prothrombin Complex Sales Value by Region

5.1.1 Global Human Prothrombin Complex Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Human Prothrombin Complex Sales Value by Region (2019-2024)

5.1.3 Global Human Prothrombin Complex Sales Value by Region (2025-2030)

5.1.4 Global Human Prothrombin Complex Sales Value by Region (%), (2019-2030)

5.2 Global Human Prothrombin Complex Sales Volume by Region

5.2.1 Global Human Prothrombin Complex Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Human Prothrombin Complex Sales Volume by Region (2019-2024)

5.2.3 Global Human Prothrombin Complex Sales Volume by Region (2025-2030)

5.2.4 Global Human Prothrombin Complex Sales Volume by Region (%), (2019-2030)

5.3 Global Human Prothrombin Complex Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Human Prothrombin Complex Sales Value, 2019-2030

5.4.2 North America Human Prothrombin Complex Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Human Prothrombin Complex Sales Value, 2019-2030

5.5.2 Europe Human Prothrombin Complex Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Human Prothrombin Complex Sales Value, 2019-2030

5.6.2 Asia Pacific Human Prothrombin Complex Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Human Prothrombin Complex Sales Value, 2019-2030

5.7.2 South America Human Prothrombin Complex Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Human Prothrombin Complex Sales Value, 2019-2030

5.8.2 Middle East & Africa Human Prothrombin Complex Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Human Prothrombin Complex Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Human Prothrombin Complex Sales Value

6.2.1 Key Countries/Regions Human Prothrombin Complex Sales Value, 2019-2030

6.2.2 Key Countries/Regions Human Prothrombin Complex Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Human Prothrombin Complex Sales Value, 2019-2030

6.3.2 United States Human Prothrombin Complex Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Human Prothrombin Complex Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Human Prothrombin Complex Sales Value, 2019-2030

6.4.2 Europe Human Prothrombin Complex Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Human Prothrombin Complex Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Human Prothrombin Complex Sales Value, 2019-2030

6.5.2 China Human Prothrombin Complex Sales Value by Type (%), 2023 VS 2030

6.5.3 China Human Prothrombin Complex Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Human Prothrombin Complex Sales Value, 2019-2030

6.6.2 Japan Human Prothrombin Complex Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Human Prothrombin Complex Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Human Prothrombin Complex Sales Value, 2019-2030

6.7.2 South Korea Human Prothrombin Complex Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Human Prothrombin Complex Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Human Prothrombin Complex Sales Value, 2019-2030

6.8.2 Southeast Asia Human Prothrombin Complex Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Human Prothrombin Complex Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Human Prothrombin Complex Sales Value, 2019-2030

6.9.2 India Human Prothrombin Complex Sales Value by Type (%), 2023 VS 2030

6.9.3 India Human Prothrombin Complex Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Takeda

7.1.1 Takeda Company Information

7.1.2 Takeda Introduction and Business Overview

7.1.3 Takeda Human Prothrombin Complex Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Takeda Human Prothrombin Complex Product Offerings

7.1.5 Takeda Recent Development

7.2 CSL

7.2.1 CSL Company Information

7.2.2 CSL Introduction and Business Overview

7.2.3 CSL Human Prothrombin Complex Sales, Revenue and Gross Margin (2019-2024)

7.2.4 CSL Human Prothrombin Complex Product Offerings

7.2.5 CSL Recent Development

7.3 Grifols

7.3.1 Grifols Company Information

7.3.2 Grifols Introduction and Business Overview

7.3.3 Grifols Human Prothrombin Complex Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Grifols Human Prothrombin Complex Product Offerings

7.3.5 Grifols Recent Development

7.4 Octapharma

7.4.1 Octapharma Company Information

7.4.2 Octapharma Introduction and Business Overview

7.4.3 Octapharma Human Prothrombin Complex Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Octapharma Human Prothrombin Complex Product Offerings

7.4.5 Octapharma Recent Development

7.5 Hualan Biological

7.5.1 Hualan Biological Company Information

7.5.2 Hualan Biological Introduction and Business Overview

7.5.3 Hualan Biological Human Prothrombin Complex Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Hualan Biological Human Prothrombin Complex Product Offerings

7.5.5 Hualan Biological Recent Development

7.6 Meheco Xinxing Pharma

7.6.1 Meheco Xinxing Pharma Company Information

7.6.2 Meheco Xinxing Pharma Introduction and Business Overview

7.6.3 Meheco Xinxing Pharma Human Prothrombin Complex Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Meheco Xinxing Pharma Human Prothrombin Complex Product Offerings

7.6.5 Meheco Xinxing Pharma Recent Development

8 Industry Chain Analysis

8.1 Human Prothrombin Complex Industrial Chain

8.2 Human Prothrombin Complex Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Human Prothrombin Complex Sales Model

8.5.2 Sales Channel

8.5.3 Human Prothrombin Complex Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Takeda

CSL Limited

Hualan Biological

Meheco Xinxing Pharma

Grifols

Grifols S A

Octapharma AG

List of Tables

Table 1. Human Prothrombin Complex Market Trends

Table 2. Human Prothrombin Complex Market Drivers & Opportunity

Table 3. Human Prothrombin Complex Market Challenges

Table 4. Human Prothrombin Complex Market Restraints

Table 5. Global Human Prothrombin Complex Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Human Prothrombin Complex Revenue Market Share by Company (2019-2024)

Table 7. Global Human Prothrombin Complex Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Human Prothrombin Complex Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Human Prothrombin Complex Price by Company (2019-2024) & (M USD/Unit)

Table 10. Key Manufacturers Human Prothrombin Complex Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Human Prothrombin Complex Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Human Prothrombin Complex

Table 13. Global Human Prothrombin Complex Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Prothrombin Complex as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Human Prothrombin Complex Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Human Prothrombin Complex Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Human Prothrombin Complex Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Human Prothrombin Complex Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Human Prothrombin Complex Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Human Prothrombin Complex Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Human Prothrombin Complex Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Human Prothrombin Complex Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Human Prothrombin Complex Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Human Prothrombin Complex Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Human Prothrombin Complex Price by Type (2019-2024) & (M USD/Unit)

Table 27. Global Human Prothrombin Complex Price by Type (2025-2030) & (M USD/Unit)

Table 28. Global Human Prothrombin Complex Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Human Prothrombin Complex Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Human Prothrombin Complex Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Human Prothrombin Complex Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Human Prothrombin Complex Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Human Prothrombin Complex Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Human Prothrombin Complex Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Human Prothrombin Complex Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Human Prothrombin Complex Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Human Prothrombin Complex Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Human Prothrombin Complex Price by Application (2019-2024) & (M USD/Unit)

Table 39. Global Human Prothrombin Complex Price by Application (2025-2030) & (M USD/Unit)

Table 40. Global Human Prothrombin Complex Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Human Prothrombin Complex Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Human Prothrombin Complex Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Human Prothrombin Complex Sales Value by Region (2019-2024) & (%)

Table 44. Global Human Prothrombin Complex Sales Value by Region (2025-2030) & (%)

Table 45. Global Human Prothrombin Complex Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Human Prothrombin Complex Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Human Prothrombin Complex Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Human Prothrombin Complex Sales Volume by Region (2019-2024) & (%)

Table 49. Global Human Prothrombin Complex Sales Volume by Region (2025-2030) & (%)

Table 50. Global Human Prothrombin Complex Average Price by Region (2019-2024) & (M USD/Unit)

Table 51. Global Human Prothrombin Complex Average Price by Region (2025-2030) & (M USD/Unit)

Table 52. Key Countries/Regions Human Prothrombin Complex Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Human Prothrombin Complex Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Human Prothrombin Complex Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Human Prothrombin Complex Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Human Prothrombin Complex Sales Volume, (2025-2030) & (K Units)

Table 57. Takeda Company Information

Table 58. Takeda Introduction and Business Overview

Table 59. Takeda Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2019-2024)

Table 60. Takeda Human Prothrombin Complex Product Offerings

Table 61. Takeda Recent Development

Table 62. CSL Company Information

Table 63. CSL Introduction and Business Overview

Table 64. CSL Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2019-2024)

Table 65. CSL Human Prothrombin Complex Product Offerings

Table 66. CSL Recent Development

Table 67. Grifols Company Information

Table 68. Grifols Introduction and Business Overview

Table 69. Grifols Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2019-2024)

Table 70. Grifols Human Prothrombin Complex Product Offerings

Table 71. Grifols Recent Development

Table 72. Octapharma Company Information

Table 73. Octapharma Introduction and Business Overview

Table 74. Octapharma Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2019-2024)

Table 75. Octapharma Human Prothrombin Complex Product Offerings

Table 76. Octapharma Recent Development

Table 77. Hualan Biological Company Information

Table 78. Hualan Biological Introduction and Business Overview

Table 79. Hualan Biological Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2019-2024)

Table 80. Hualan Biological Human Prothrombin Complex Product Offerings

Table 81. Hualan Biological Recent Development

Table 82. Meheco Xinxing Pharma Company Information

Table 83. Meheco Xinxing Pharma Introduction and Business Overview

Table 84. Meheco Xinxing Pharma Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2019-2024)

Table 85. Meheco Xinxing Pharma Human Prothrombin Complex Product Offerings

Table 86. Meheco Xinxing Pharma Recent Development

Table 87. Key Raw Materials Lists

Table 88. Raw Materials Key Suppliers Lists

Table 89. Human Prothrombin Complex Downstream Customers

Table 90. Human Prothrombin Complex Distributors List

Table 91. Research Programs/Design for This Report

Table 92. Key Data Information from Secondary Sources

Table 93. Key Data Information from Primary Sources

List of Figures

Figure 1. Human Prothrombin Complex Product Picture

Figure 2. Global Human Prothrombin Complex Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Human Prothrombin Complex Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Human Prothrombin Complex Sales Volume (2019-2030) & (K Units)

Figure 5. Global Human Prothrombin Complex Sales Price (2019-2030) & (M USD/Unit)

Figure 6. Human Prothrombin Complex Report Years Considered

Figure 7. Global Human Prothrombin Complex Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Human Prothrombin Complex Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Prothrombin Complex Revenue in 2023

Figure 10. Human Prothrombin Complex Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. 500 IU/Vial Picture

Figure 12. 600 IU/Vial Picture

Figure 13. 1000 IU/Vial Picture

Figure 14. Others Picture

Figure 15. Global Human Prothrombin Complex Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 16. Global Human Prothrombin Complex Sales Value Market Share by Type, 2023 & 2030

Figure 17. Global Human Prothrombin Complex Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 18. Global Human Prothrombin Complex Sales Volume Market Share by Type, 2023 & 2030

Figure 19. Global Human Prothrombin Complex Price by Type (2019-2030) & (M USD/Unit)

Figure 20. Product Picture of Hemophilia B

Figure 21. Product Picture of Vitamin K Deficiency

Figure 22. Product Picture of Others

Figure 23. Global Human Prothrombin Complex Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 24. Global Human Prothrombin Complex Sales Value Market Share by Application, 2023 & 2030

Figure 25. Global Human Prothrombin Complex Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 26. Global Human Prothrombin Complex Sales Volume Market Share by Application, 2023 & 2030

Figure 27. Global Human Prothrombin Complex Price by Application (2019-2030) & (M USD/Unit)

Figure 28. North America Human Prothrombin Complex Sales Value (2019-2030) & (US$ Million)

Figure 29. North America Human Prothrombin Complex Sales Value by Country (%), 2023 VS 2030

Figure 30. Europe Human Prothrombin Complex Sales Value (2019-2030) & (US$ Million)

Figure 31. Europe Human Prothrombin Complex Sales Value by Country (%), 2023 VS 2030

Figure 32. Asia Pacific Human Prothrombin Complex Sales Value (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Human Prothrombin Complex Sales Value by Country (%), 2023 VS 2030

Figure 34. South America Human Prothrombin Complex Sales Value (2019-2030) & (US$ Million)

Figure 35. South America Human Prothrombin Complex Sales Value by Country (%), 2023 VS 2030

Figure 36. Middle East & Africa Human Prothrombin Complex Sales Value (2019-2030) & (US$ Million)

Figure 37. Middle East & Africa Human Prothrombin Complex Sales Value by Country (%), 2023 VS 2030

Figure 38. Key Countries/Regions Human Prothrombin Complex Sales Value (%), (2019-2030)

Figure 39. Key Countries/Regions Human Prothrombin Complex Sales Volume (%), (2019-2030)

Figure 40. United States Human Prothrombin Complex Sales Value, (2019-2030) & (US$ Million)

Figure 41. United States Human Prothrombin Complex Sales Value by Type (%), 2023 VS 2030

Figure 42. United States Human Prothrombin Complex Sales Value by Application (%), 2023 VS 2030

Figure 43. Europe Human Prothrombin Complex Sales Value, (2019-2030) & (US$ Million)

Figure 44. Europe Human Prothrombin Complex Sales Value by Type (%), 2023 VS 2030

Figure 45. Europe Human Prothrombin Complex Sales Value by Application (%), 2023 VS 2030

Figure 46. China Human Prothrombin Complex Sales Value, (2019-2030) & (US$ Million)

Figure 47. China Human Prothrombin Complex Sales Value by Type (%), 2023 VS 2030

Figure 48. China Human Prothrombin Complex Sales Value by Application (%), 2023 VS 2030

Figure 49. Japan Human Prothrombin Complex Sales Value, (2019-2030) & (US$ Million)

Figure 50. Japan Human Prothrombin Complex Sales Value by Type (%), 2023 VS 2030

Figure 51. Japan Human Prothrombin Complex Sales Value by Application (%), 2023 VS 2030

Figure 52. South Korea Human Prothrombin Complex Sales Value, (2019-2030) & (US$ Million)

Figure 53. South Korea Human Prothrombin Complex Sales Value by Type (%), 2023 VS 2030

Figure 54. South Korea Human Prothrombin Complex Sales Value by Application (%), 2023 VS 2030

Figure 55. Southeast Asia Human Prothrombin Complex Sales Value, (2019-2030) & (US$ Million)

Figure 56. Southeast Asia Human Prothrombin Complex Sales Value by Type (%), 2023 VS 2030

Figure 57. Southeast Asia Human Prothrombin Complex Sales Value by Application (%), 2023 VS 2030

Figure 58. India Human Prothrombin Complex Sales Value, (2019-2030) & (US$ Million)

Figure 59. India Human Prothrombin Complex Sales Value by Type (%), 2023 VS 2030

Figure 60. India Human Prothrombin Complex Sales Value by Application (%), 2023 VS 2030

Figure 61. Human Prothrombin Complex Industrial Chain

Figure 62. Human Prothrombin Complex Manufacturing Cost Structure

Figure 63. Channels of Distribution (Direct Sales, and Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global ECG And EEG Testing Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-29U9219

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Mammography Equipment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-33G9187

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Combined Angiography Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-10A6252

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Mammography Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-36N6053

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions